Novo Nordisk Halves Wegovy Prices: A Turning Point for Diabetes and Weight Loss Drugs
Novo Nordisk announces a significant price reduction for Wegovy and Ozempic, dropping to $675 per month starting January 2027, reflecting the intense competition in the pharmaceutical sector. This move raises important questions about accessibility and market dynamics.
Read full article



























